C-erbB-2-future biological marker of breast cancer chemotherapy
- VernacularTitle:c-erbB-2—未来乳腺癌化疗的生物学标志物
- Author:
Jing CHENG
;
Jie XU
;
Yunfeng ZHOU
;
- Publication Type:Journal Article
- Keywords:
c erbB 2;
breast cancer;
chemotherapy
- From:
China Oncology
2001;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
C erbB 2 is overexpressed in 20%~30% of human breast cancers,this oncoprotein plays an important role in predicting response to chemotherapy in breast cancer.Overexpression of c erbB 2 in breast cancer is associated with resistance or sensitivity to certain chemo therapeutic drugs, c erbB 2 can be expected to be a biological marker to direct chemotherapy in the treatment of breast cancer.